In a significant U-turn, British-Swedish pharmaceutical company AstraZeneca recently admitted in court documents that its COVID-19 vaccine can cause deadly blood clots. Submitted in response to a class action lawsuit currently underway in the UK High Court, the move comes as deaths and severe injuries from the injection are increasingly resulting in plaintiffs seeking substantial damages. Developed in collaboration with Oxford University in the UK and produced by the Serum Institute of India, the vaccine is understood to have also triggered similar legal action against the firm in Italy, Germany, and other countries.
Representing a dramatic shift from its previous stance, AstraZeneca has specifically acknowledged that its vaccine can lead to Thrombosis with Thrombocytopenia Syndrome (TTS), a condition characterized by blood clotting and low platelet levels. The admission, contained in court documents, contrasts with the company’s previous assertions denying a direct link with the syndrome. With over fifty cases filed in the UK High Court, claimants and affected families are seeking damages expected to be worth up to £100 million. Some suggest the final compensation bill could even reach as high as £255 million.
To read how the Dr. Rath Research Institute has developed a revolutionary micronutrient combination that is effective against not only the original virus responsible for COVID-19 but also a number of its variants, see this article on our website.
Magnesium May Mitigate Muscle Soreness
August 30, 2024One Million Brain Scans Used to Assess Dementia Risk
August 30, 2024AstraZeneca Vaccine Deaths: Families Ask Why Warnings Not Shared
News
The parents of a young woman who died after being given an AstraZeneca Covid jab have accused the UK’s National Health Service (NHS) of failing to pass on known safety warnings about the vaccine.
[Source: bbc.co.uk]
[Image source: Adobe Stock]
Comment
In a significant U-turn, British-Swedish pharmaceutical company AstraZeneca recently admitted in court documents that its COVID-19 vaccine can cause deadly blood clots. Submitted in response to a class action lawsuit currently underway in the UK High Court, the move comes as deaths and severe injuries from the injection are increasingly resulting in plaintiffs seeking substantial damages. Developed in collaboration with Oxford University in the UK and produced by the Serum Institute of India, the vaccine is understood to have also triggered similar legal action against the firm in Italy, Germany, and other countries.
Representing a dramatic shift from its previous stance, AstraZeneca has specifically acknowledged that its vaccine can lead to Thrombosis with Thrombocytopenia Syndrome (TTS), a condition characterized by blood clotting and low platelet levels. The admission, contained in court documents, contrasts with the company’s previous assertions denying a direct link with the syndrome. With over fifty cases filed in the UK High Court, claimants and affected families are seeking damages expected to be worth up to £100 million. Some suggest the final compensation bill could even reach as high as £255 million.
To read how the Dr. Rath Research Institute has developed a revolutionary micronutrient combination that is effective against not only the original virus responsible for COVID-19 but also a number of its variants, see this article on our website.
Dr. Rath Health Foundation
Related posts
Opioid Painkillers Put Millions at Risk of Addiction or Dependency
Read more